News
FDA Suspends U.S. License of Chikungunya Vaccine
By Stephanie Brown HealthDay ReporterMONDAY, Aug. 25, 2025 (HealthDay News) -- The U.S. Food and Drug Administration is suspending the biologics license for the live-attenuated chikungunya vaccine, Ixchiq, in the United States. The move comes after reports of serious side effects in older adults similar to the symptoms of chikungunya virus.
FDA does a 180, suspending use of Valneva's chikungunya vaccine
Less than three weeks after lifting a pause on the use of Valneva’s chikungunya vaccine Ixchiq, the FDA has done an about-face, banning the use of the shot in the United States. | Less than three weeks after lifting a pause on the use of Valneva’s chikungunya vaccine Ixchiq,
The recalls have been classified as Class II, where the probability of serious adverse health consequences is remote.
MedPage Today on MSN14h
In Abrupt Reversal, FDA Yanks Ixchiq Vaccine Over Safety Concern
According to the vaccine's maker, Valneva, the FDA based its decision to suspend the shot on four new serious adverse events ...
The FDA is warning that nitrous oxide, commonly known as “laughing gas," is being misused as a recreational drug.
The FDA has broadened the indication for evolocumab (Repatha; Amgen) to include adults at increased risk of major adverse ...
In a fact sheet, the agency noted that high concentrations of oxygen pose a risk for fire, "which is one reason why the FDA recommends treatment at an accredited facility. Explosions and fires have ...
The U.S. Food & Drug Administration (FDA) has announced a recall on a limited lot of Blue Bell Ice Cream due to the presence ...
The FDA Adverse Event Reporting System, which Commissioner Marty Makary called “clunky,” previously published updates on a ...
The FDA said it has begun publishing reports of adverse events concerning drugs on a daily basis, instead of quarterly, as it ...
HHS announced Aug. 22 it plans to decertify union representation in several agencies, which would affect thousands of agency employees, according to the American Federation of Government Employees. ...
Although VIZZ is, so far, the first and only FDA-approved aceclidine eye drop, it’s one of three prescription eye drops ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback